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Summary
Supernumerary centrosomes are a key cause of genomic
instability in cancer cells [1]. New centrioles can be gener-
ated by duplication with a mother centriole as a platform
or, in the absence of preexisting centrioles, by formation
de novo [2]. Polo-like kinase 4 (Plk4) regulates both modes
of centriole biogenesis, and Plk4 deregulation has been
linked to tumor development [1, 3]. We show that Plx4, the
Xenopus homolog of mammalian Plk4 and Drosophila Sak,
induces de novo centriole formation in vivo in activated
oocytes and in egg extracts, but not in immature or in vitro
matured oocytes. Both kinase activity and the polo-box
domain of Plx4 are required for de novo centriole biogen-
esis. Polarization microscopy in ‘‘cycling’’ egg extracts
demonstrates that de novo centriole formation is indepen-
dent of Cdk2 activity, a major difference compared to
template-driven centrosome duplication that is linked to
the nuclear cycle and requires cyclinA/E/Cdk2. Moreover,
we show that the Mos-MAPK pathway blocks Plx4-depen-
dent de novo centriole formation before fertilization, thereby
ensuring paternal inheritance of the centrosome. The results
define a new system for studying the biochemical and
molecular basis of de novo centriole formation and centriole
biogenesis in general.
Results
We sought to study the effects of Polo-like kinase 4 (Plx4), the
Xenopus homolog of mammalian Plk4, in a centriole-free
system using Xenopus oocytes and egg extracts. Plx4 overex-
pression in immature (stage VI) oocytes did not result in any
obvious phenotype (Figure 1A, left panels), and the same
was true in oocytes treated with progesterone (PG) to undergo
meiotic maturation in vitro, producing eggs arrested at meta-
phase of meiosis II (Figure 1A, middle panels). Maturation in
oocytes overexpressing Plx4 occurred with kinetics similar
to those of control oocytes (Figure S1A available online).
However, in vitro matured oocytes (eggs) expressing Plx4
that were subsequently activated with the calcium ionophore
A23187 developed speckled-like pigmentation on their surface
(Figure 1A, lower right panel). These speckles appeared begin-
ning 2 hr after activation, and their numbers increased rapidly
over time (Figure S1B). The appearance of pigmented
speckles after activation was not caused by changes in Plx4
activity, because Plx4 activity before and after activation was
the same (Figure 1B, right panel, lanes 2 and 3). This result*Correspondence: Jim.Maller@ucdenver.edu
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College of Medicine, Chicago, IL 60612, USAsuggests that Plx4 activity is not regulated by upstream
factors induced after oocyte maturation or egg fertilization,
in contrast to other Plk family members, such as Plk1 [4, 5].
Although Plx4 activity did not change after activation, its
kinase activity was essential for inducing the speckled pheno-
type, because kinase-dead Plx4 (Plx4-NA) failed to induce
speckles in activated oocytes (Figure 1C and Figure S1B, third
column). Of all Plks, Plk4 is the most divergent family member,
as it does not exhibit the canonical two polo-boxes (PBs)
important for phospho-substrate recognition by Plks1-3.
Instead, Plk4 contains one polo-box preceded by a cryptic
polo-box (cry-PB) that promotes homodimerization of the
kinase [6]. Thus, we tested whether a functional polo-box
domain (PBD), encompassing both the PB and the cry-PB, is
required for the pigmented speckle phenotype in activated
oocytes. Expression of kinase-active Plx4 in which the PBD
was deleted (Plx4-DPB) did not induce pigmented speckles
after oocyte activation (Figure 1C and Figure S1B, last
column).
During frog female meiosis, all maternal centrioles are
lost and the meiotic spindle is acentrosomally formed. The
speckled phenotype of ionophore-activated oocytes express-
ing Plx4 resembled the appearance of eggs activated by injec-
tion of centriole-containing fractions from sea urchin sperm
[7]. Such eggs were found to contain a large number of asters
near the surface. To analyze the speckled oocytes expressing
Plx4, we performed whole-mount immunostaining using
confocal laserscan microscopy and observed that only the
speckled oocytes, but not control oocytes (or oocytes injected
with Plx4-NA or Plx4-DPB), exhibited a large number of
a-tubulin asters (Figures 1D and 1E, left panels, and data not
shown). At their cores, these asters also contained g-tubulin
(Figures 1D–1F, middle panels) and polyglutamylated (polyE)
tubulin (Figure 1F, left panel), indicating that they emanate
from centrosomal structures. These results suggest that
oocyte speckles reflect microtubular asters nucleated by
Plx4-induced, de novo-formed centrioles and that both kinase
activity and a functional PBD are required to induce this
phenotype. The absence of de novo centrosomes in immature
and mature oocytes (see Figure 1A, left and middle panels)
even when Plx4 expression is high suggests that a preexisting
centriole is not required to block de novo centriole formation in
oocytes and eggs.
To investigate the pathway of de novo centriole formation,
we used polarization microscopy to analyze extracts from
Xenopus unfertilized eggs activated by calcium ionophore,
a system previously used to study the role of cyclin E/Cdk2
in conventional centrosome duplication [8]. When sperm
chromatin was added to extracts, providing centrosomes in
the form of the basal body, asters formed immediately, both
in the absence and in the presence of ectopic Plx4, and these
asters duplicated over time (Figure 2A, upper and middle
panels). In extracts without sperm but supplemented with
Plx4, no asters were observed initially, but after two hours—
a time when speckles first appeared on the surface of acti-
vated oocytes (see Figure S1B)—asters started to form de
novo (Figure 2A, lower panels). In agreement with the results
from activated oocytes (see Figure S1B), only wild-type Plx4,
Figure 1. Plx4 Induces De Novo Centriole Formation in Activated Eggs
(A) Immature (stage VI) oocytes were injected with buffer (control) or mRNA
encoding Plx4 and incubated overnight. Some oocytes were then stimu-
lated with PG (middle column), and some of the resulting matured oocytes
(arrested at metaphase of meiosis II) were activated with the calcium iono-
phore A23187 (right column). The surface of activated Plx4-expressing
oocytes exhibited pigmented speckles (lower right panel). Scale bar repre-
sents 1 mm.
(B) Immune-complex kinase assays of Myc-Plx4 from immature oocytes
(lane 1), PG-treated oocytes arrested at MII (lane 2) and calcium iono-
phore-activated oocytes (lane 3), as in (A). Left, autoradiograph of Plx4
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429but not Plx4-NA or Plx4-DPB, induced aster formation in egg
extracts (Figure 2B). Immunostaining revealed that these
asters contained a-tubulin with g-tubulin at their core (Fig-
ure 2C). The g-tubulin cores of these asters also costained
for tubulin modifications frequently found to be enriched on
centrioles, such as polyglutamylated tubulin (Figure 2D) and
acetylated tubulin (Figure 2E) [9, 10]. More importantly, they
also costained for centrin (Figure 2F) and SAS-6 (Figure 2G),
two centriole-specific markers [11, 12]. Thus, the asters
formed in egg extracts overexpressing Plx4 represent func-
tional centriolar structures able to nucleate microtubular
asters.
It was previously demonstrated that cyclin E/Cdk2 activity is
required for centrosome duplication in Xenopus, as addition of
the Cdk2 inhibitor D34p27Xic1 prevents multiple rounds of
centrosome duplication in egg extracts [8]. Interestingly, in
extracts expressing Plx4, D34p27Xic1 did not prevent de
novo centriole formation (Figure 3A, middle panels). These
results indicate that Cdk2 activity is dispensable for de novo
centriole formation. Microinjection of D34p27Xic1 mechanically
activated in vitro matured oocytes (eggs) overexpressing Plx4
but did not prevent the appearance of pigmented speckles
similar to those in ionophore-activated oocytes expressing
Plx4 alone (Figure 3B). D34p27Xic1 inhibited Cdk2 activity, as
demonstrated by persistent inhibitory Cdk phosphorylation
at Tyr15 (Figure 3C, lower panels).
During oocyte maturation, the MAPK kinase kinase
(MAPKKK) Mos is synthesized from maternal mRNA, which
leads to activation of the MEK1-MAPK-p90Rsk pathway [13]
(for review see [14]). After addition of calcium ionophore,
Mos is degraded in the egg, resulting in MAPK inactivation
[15]. Given the observation that pigmented speckles appear
only in activated eggs after Mos has been degraded, we inves-
tigated whether theMos-MAPK pathwaymight be responsible
for blocking Plx4-induced centriole formation in unfertilized
eggs. Interestingly, when egg extracts were supplemented
with Mos, leading to MAPK activation (Figure 3C, middle
row), Plx4 was unable to induce de novo centriole formation
(Figure 3A, lower panels). Mos-dependent activation of the
MAPK pathway promotes arrest of the unfertilized egg in
metaphase II by cytostatic factor (CSF) [14]. To determine
whether inhibition of centriole formation was due to other
mitotic activities, such as cyclin B/Cdk1, rather than a direct
effect of MAPK activation, we used the Cdk inhibitor roscovi-
tine to arrest egg extracts in interphase. In the presence ofautophosphorylation (upper panel) or phosphorylation of MBP (lower
panel). Right: Myc-Western blot of Plx4 (upper panel) and Coomassie stain-
ing of MBP (lower panel).
(C) Immature (stage VI) oocytes were injected with mRNAs encoding wild-
type Plx4, kinase-dead Plx4-NA, or truncated Plx4 lacking both the PB
and the cry-PB (Plx4-DPB), as indicated. Then, as in (A), PG was added to
induce maturation to MII, and activation was subsequently induced by
calcium ionophore treatment. The morphology of oocytes 3 hr after calcium
ionophore is shown. A detailed time course analysis is presented in Fig-
ure S1B.
(D–F) Plx4 overexpression inducesmicrotubular asters in activated oocytes.
Immature oocytes were injected with mRNA for Plx4 and treated as in (C);
then, 3 hr after activation with calcium ionophore, they were analyzed by
whole-mount immunostaining as described in Supplemental Experimental
Procedures. (D) Activated oocytes expressing Plx4 and exhibiting speckles
(as in A, lower right) are filled with numerous microtubular asters that have
g-tubulin foci at their core (red, a-tubulin; blue, g-tubulin; right panel,
merge). (E) Some asters contain several g-tubulin foci (staining as in D).
(F) g-tubulin foci (blue) costain for polyglutamylated (polyE) tubulin (red).
Scale bar in (D) represents 20 mm; scale bars in (E) and (F) represent 10 mm.
Figure 2. Plx4-Induced De Novo Centriole For-
mation Requires Kinase Activity and the PBD
(A) Xenopus ‘‘cycling’’ egg extracts from
activated eggs were supplemented with (upper
and middle panels) or without (lower panels)
demembranated sperm chromatin and moni-
tored for centrosome duplication by polarization
microscopy as described in Supplemental Exper-
imental Procedures.
(B) Extracts expressing Plx4 (second row), but
not control extracts (upper row) or extracts
expressing Plx4-NA (third row) or Plx4-DPB
(fourth row), form centrosomes de novo.
(A) and (B) are polarization microscopy images:
left panels, 0 hr; right panels, 2 hr after incuba-
tion. Scale bar represents 100 mm.
(C–G) Immunofluorescence of Plx4-induced
de novo microtubular asters in egg extracts 5 hr
(C, D, F) and 2 hr (E, G) after incubation. (C)
Plx4-NA (upper panel)- and Plx4 (lower panels)-
expressing extracts were stained for a-tubulin
(green, left panels) and g-tubulin (red, middle
panels). (D–G): g-tubulin foci (red, middle panels)
were costained for polyglutamylated tubulin (D),
acetylated a-tubulin (E), centrin (F), or SAS-6 (G)
(green, left panels). Scale bar represents 5 mm.
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430roscovitine and Plx4, asters formed after 2 hr (Figure 3D, upper
panels), but when these extracts also contained Mos, aster
formation was prevented (Figure 3D, lower panels). Western
blot analysis confirmed that extracts were arrested in inter-
phase, as shown by persistent inhibitory phosphorylation of
Cdk1 on Tyr15 (Figure 3E). These results demonstrate that
inhibition of de novo centriole formation is not due to
secondary effects of M-phase but rather to activation of the
Mos-MAPK pathway.
Although centriolar microtubules are exceptionally stable,
inhibiting tubulin glutamylation with neutralizing antibodies in
human cells induces rapid but transient disassembly of exist-
ing centrioles [9]. Given that activation of the MAPK pathway
by Mos is sufficient to prevent de novo centriole formation
induced by Plx4, we investigated whether it could also reversethis process after centriole formation
had been initiated. To this end, we
addedMos to extracts after 2 hr of incu-
bation, a time when centrioles had just
started to form. Aster numbers
continued to increase after Mos addi-
tion, indicating that once centriole
formation is initiated, Mos is unable to
reverse this process (Figure S2A).
Thus, the Mos-MAPK pathway is able
to prevent early steps of centriole
formation but cannot promote centriole
disassembly.
Given that activation of MAPK is suffi-
cient to block de novo centriole forma-
tion in interphase egg extracts lacking
Mos (see Figure 3D), we wondered
whether inhibition of the MAPK pathway
by U0126 would promote de novo
centriole formation in intact eggs ar-
rested at metaphase II with high Mos-
MAPK activity [14]. To this end, we incu-
bated Plx4-expressing in vitro maturedoocytes with DMSO (control) or U0126 and assessed speckle
formation. Whereas control oocytes expressing Plx4 did not
develop speckles, oocytes exposed to U0126 produced
speckles similar to those formed after calcium ionophore
treatment (Figure 3F). U0126-mediated inhibition of MAPK
was confirmed by Western blot analysis of phospho-MAPK
(Figure 3G). To further substantiate this finding, we utilized
extracts from eggs arrested at metaphase of meiosis II by
CSF. We added Plx4 protein purified from Sf9 cells without
or with CaCl2 to induce CSF release, meiotic exit, and entry
into interphase. Plx4 addition without calcium did not cause
aster formation (Figure S2B, left panels), whereas Plx4 addi-
tion with calcium induced CSF release and aster formation
(Figure S2B, right panels). Importantly, addition of Plx4
and U0126 caused aster formation without calcium addition
Figure 3. Plx4-Induced De Novo Centriole
Formation Is Independent of Cdk2 But Inhibited
by MAPK
(A) Plx4 induces asters in control ‘‘cycling’’ egg
extracts (upper panels) and in the presence of
350 nM D34p27Xic1 (middle panels) but not in
the presence of Mos (lower panels). Left panels:
0 hr; right panels: 3 hr after incubation. Polariza-
tion microscopy images are shown.
(B) Oocytes expressing Plx4 and stimulated with
PG to reach MII (egg) were generated as in Fig-
ure1A,except thatactivationwas inducedmechan-
ically by microinjection of buffer or D34p27Xic1.
Images depict oocytes 3 hr after activation.
(C) Western blot analysis of egg extracts in (A).
Plx4 detected by anti-Myc antibody (upper
panels); the activated form of MAPK (middle
panels); and inhibitory phosphorylation of Cdk2
(pY15) (lower panels).
(D) Plx4-expressing egg extracts treated with
roscovitine alone (upper panels) or also in the
presence of Mos (lower panels). Images show
0 hr and 2 hr after incubation with roscovitine.
(A) and (D) are polarization microscopy images;
scale bar represents 100 mm.
(E) The egg extracts in panel (D) were analyzed for
inhibitory Cdk phosphorylation by Western blot.
(F) Plx4-expressing Xenopus oocytes arrested in
MII after PG treatment were incubated with
DMSO (control, left panel) or with 50 mM U0126
(middle panel) or were activated with calcium
ionophore (right panel). Images depict oocytes
2.5 hr after treatment.
(G) Western blot analysis of oocytes in (F) moni-
toring the activated form of MAPK at the indi-
cated times.
Plx4-Induced De Novo Centriole Formation
431(Figure S2B,middle panels). Thus,MAPK is necessary to block
Plx4-induced de novo centriole formation, as judged by
speckle formation in in vitro matured oocytes and aster forma-
tion in CSF extracts.
Discussion
Sak overexpression has been reported to induce de novo
centriole formation in flies [16, 17]. Our results illustrate the
fundamental nature of this process by demonstrating that
Plx4-induced de novo centriole formation is conserved in
vertebrates. Both an intact PBD and kinase activity are
required for this function. It was particularly important to deter-
mine whether kinase activity was required, in part because it
was recently reported that expression of kinase-dead Plk4
induces centrosome overduplication in human cells [18]. Over-
duplication was mediated by homodimerization of kinase-
dead Plk4 with endogenous Plk4, blocking bTrCP-mediated
degradation. However, expression of kinase-dead Plx4 did
not induce de novo centriole formation in our system. Whether
this reflects a major difference between normal centrosome
duplication and de novo centriole formation requires further
analysis.
Our results revisit several hypotheses about centriole
biogenesis. First, it has been proposed that canonical centriole
replicationmay depend upon the presence of centriole precur-
sors in the cytoplasm but that during replication only one of
these precursors becomes stabilized when it contacts the
mother centriole [19]. This hypothesis predicts that Plx4 over-
expression should induce de novo centriole formation inoocytes at all stages. However, only after oocytes were acti-
vatedbycalcium ionophoredid centrioles formdenovo. There-
fore, centriole formation is not simply induced by stabilization
of precursors but is additionally regulated by cytoplasmic
enzymes that promote or inhibit de novo centriole formation.
Overexpression of Plk4 or cyclin E is required for centro-
some overduplication in mammalian cells, but neither protein
can induce centrosome amplification in the absence of the
other [20]. The evidence here that Cdk2 activity is dispensable
for de novo centriole formation indicates that the de novo and
duplication pathways are regulated very differently. Themech-
anism by which DNA replication and centrosome duplication
are coordinated to maintain control of centriole number is still
largely unknown. Recent emerging evidence indicates that
cyclin E/Cdk2 activity on the centrosome is required to link
the nuclear cycle with the centrosome duplication cycle.
For example, DNA replication factors inhibit centrosome
overduplication by interacting with cyclin A/E/Cdk2 on the
centrosome [21, 22]. Centrosome overduplication from
a mother centrosome requires Cdk2/cyclin A/E activity, but
we show here that de novo formation does not. As de novo
centriole formation occurs in the absence of DNA replication
and Cdk2 activity, our data also indicate that the de novo
pathway is independent of DNA synthesis (the nuclear cycle).
However, it is not independent of the cell cycle, because we
never observed de novo centriole formation in egg extracts
arrested in mitosis (data not shown). Cdk2-independent regu-
lation might explain why centrioles form in variable numbers
independently of the nuclear cycle, as the de novo pathway
exhibits loss of numerical control over centrioles [23].
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432It has been proposed that preexisting centrioles are the
major antagonists of de novo centriole formation, because
de novo centriole formation has never been observed in cells
with a preexisting mother centriole [19]. We show here in
a centriole-free system that cytoplasmic factors, such as
Mos-MAPK activity, are sufficient to block the de novo
pathway. The high MAPK pathway activity may be responsible
for blocking de novo formation in themetaphase II arrested un-
fertilized egg, given that reactivation of the MAPK pathway in
‘‘cycling’’ egg extracts blocked de novo formation. In addition,
inhibition of MAPK activity appears sufficient to induce de
novo centriole formation in the intact matured oocyte (egg),
as judged by speckles (see Figure 3F), or in CSF extracts, as
judged by aster formation (Figure S2B). CSF activity induces
a stable metaphase II arrest that maintains the egg in a recep-
tive state for fertilization. The aspect of CSF arrest that has
received the most attention is inhibition of APC/C activation
by Cdc20. This inhibition is largely a consequence of produc-
tion in meiosis II of Emi2, an APC/C inhibitor [24, 25]. Our
results suggest that another aspect of CSF arrest mediated
by the Mos-MAPK-p90Rsk pathway is prevention of de novo
centriole formation. This may explain how eggs arrested in
M-phase and awaiting fertilization prevent centriole formation
to ensure that the centrosome used in development is pater-
nally inherited. It will be interesting to investigate whether
MAPK, or other enzymes in this pathway, also blocks the de
novo pathway in somatic cells after preexisting centrosomes
are removed.
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